Literature DB >> 16152606

Carrier frequency of mutation 657del5 in the NBS1 gene in a population of Polish pediatric patients with sporadic lymphoid malignancies.

Krystyna H Chrzanowska1, Dorota Piekutowska-Abramczuk, Ewa Popowska, Małgorzata Gładkowska-Dura, Jadwiga Małdyk, Małgorzata Syczewska, Małgorzata Krajewska-Walasek, Bozenna Goryluk-Kozakiewicz, Halina Bubała, Artur Gadomski, Anna Gaworczyk, Bernarda Kazanowska, Andrzej Kołtan, Marta Kuźmicz, Teresa Luszawska-Kutrzeba, Lucyna Maciejka-Kapuścińska, Małgorzata Stolarska, Katarzyna Stefańska, Katarzyna Sznurkowska, Anna Wakulińska, Maria Wieczorek, Tomasz Szczepański, Jerzy Kowalczyk.   

Abstract

Nijmegen breakage syndrome (NBS) is a human autosomal recessive disease characterized by genomic instability and enhanced cancer predisposition, in particular to lymphoma and leukemia. Recently, significantly higher frequencies of heterozygous carriers of the Slavic founder NBS1 mutation, 657del5, were found in Russian children with sporadic lymphoid malignancies, and in Polish adults with non-Hodgkin lymphoma (NHL). In addition, the substitution 643C>T (R215W) has also been found in excess among children with acute lymphoblastic leukemia (ALL). In an attempt to asses the contribution of both mutations to the development of sporadic lymphoid malignancies, we analyzed DNA samples from a large group of Polish pediatric patients. The NBS1 mutation 657del5 on one allele was found in 3 of 270 patients with ALL and 2 of 212 children and adolescents with NHL; no carrier was found among 63 patients with Hodgkin lymphoma (HL). No carriers of the variant R215W were detected in any studied group. The relative frequency of the 657del5 mutation was calculated from a total of 6,984 controls matched by place of patient residence, of whom 42 were found to be carriers (frequency = 0.006). In the analyzed population with malignancies, an increased odds ratio for the occurrence of mutation 657del5 was found in comparison with the control Polish population (OR range 1.48-1.85, 95% confidence interval 1.18-2.65). This finding indicates that the frequency of the mutation carriers was indeed increased in patients with ALL and NHL (p < 0.05). Nonetheless, NBS1 gene heterozygosity is not a major risk factor for lymphoid malignancies in childhood and adolescence. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16152606     DOI: 10.1002/ijc.21439

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

Review 1.  A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes.

Authors:  Sarah Scollon; Amanda Knoth Anglin; Martha Thomas; Joyce T Turner; Kami Wolfe Schneider
Journal:  J Genet Couns       Date:  2017-03-29       Impact factor: 2.537

2.  Clinical significance of increased expression of Nijmegen breakage syndrome gene (NBS1) in human primary liver cancer.

Authors:  Yan Wang; Man Li; Jiang Long; Xiao-Yan Shi; Qian Li; Jia Chen; Wei-Min Tong; Ji-Dong Jia; Jian Huang
Journal:  Hepatol Int       Date:  2014-01-29       Impact factor: 6.047

3.  The frequency of NBN molecular variants in pediatric astrocytic tumors.

Authors:  Dorota Piekutowska-Abramczuk; Elzbieta Ciara; Ewa Popowska; Wiesława Grajkowska; Bozenna Dembowska-Bagińska; Ewa Kowalewska; Aneta Czajńska; Marta Perek-Polnik; Marcin Roszkowski; Małgorzata Syczewska; Małgorzata Krajewska-Walasek; Danuta Perek; Krystyna H Chrzanowska
Journal:  J Neurooncol       Date:  2009-07-22       Impact factor: 4.130

Review 4.  Mystery of DNA repair: the role of the MRN complex and ATM kinase in DNA damage repair.

Authors:  Kamila Czornak; Sanaullah Chughtai; Krystyna H Chrzanowska
Journal:  J Appl Genet       Date:  2008       Impact factor: 3.240

5.  An inherited NBN mutation is associated with poor prognosis prostate cancer.

Authors:  C Cybulski; D Wokołorczyk; W Kluźniak; A Jakubowska; B Górski; J Gronwald; T Huzarski; A Kashyap; T Byrski; T Dębniak; A Gołąb; B Gliniewicz; A Sikorski; J Switała; T Borkowski; A Borkowski; A Antczak; L Wojnar; J Przybyła; M Sosnowski; B Małkiewicz; R Zdrojowy; P Sikorska-Radek; J Matych; J Wilkosz; W Różański; J Kiś; K Bar; P Bryniarski; A Paradysz; K Jersak; J Niemirowicz; P Słupski; P Jarzemski; M Skrzypczyk; J Dobruch; P Domagała; S A Narod; J Lubiński
Journal:  Br J Cancer       Date:  2012-11-13       Impact factor: 7.640

Review 6.  Genetic susceptibility in childhood acute leukaemias: a systematic review.

Authors:  Gisele D Brisson; Liliane R Alves; Maria S Pombo-de-Oliveira
Journal:  Ecancermedicalscience       Date:  2015-05-14

7.  NBN Gene Polymorphisms and Cancer Susceptibility: A Systemic Review.

Authors:  Francesco Berardinelli; Alessandra di Masi; Antonio Antoccia
Journal:  Curr Genomics       Date:  2013-11       Impact factor: 2.236

8.  NBS1 Heterozygosity and Cancer Risk.

Authors:  Alessandra di Masi; Antonio Antoccia
Journal:  Curr Genomics       Date:  2008-06       Impact factor: 2.236

9.  Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma.

Authors:  Johanna M Schuetz; Amy C MaCarthur; Stephen Leach; Agnes S Lai; Richard P Gallagher; Joseph M Connors; Randy D Gascoyne; John J Spinelli; Angela R Brooks-Wilson
Journal:  BMC Med Genet       Date:  2009-11-16       Impact factor: 2.103

10.  Mutation inactivation of Nijmegen breakage syndrome gene (NBS1) in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

Authors:  Yan Wang; Yu Hong; Man Li; Jiang Long; Yan-Ping Zhao; Jun-Xia Zhang; Qian Li; Hong You; Wei-Min Tong; Ji-Dong Jia; Jian Huang
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.